Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 334

The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.

Principles of antibacterial dosing in continuous renal replacement therapy

Choi, Gordon, Gomersall, Charles D., Tian, Qi, Joynt, Gavin M., Freebairn, Ross, Lipman, Jeffrey · 2009 · Critical Care Medicine

Abstract

OBJECTIVES: To outline the concepts involved in optimizing antibacterial dosing in critically ill patients with acute renal failure undergoing continuous renal replacement therapy (CRRT), provide a strategy for optimizing dosing, and summarize the data required to implement the strategy. DATA SOURCES: MEDLINE search from February 1986 to 2008. DATA EXTRACTION AND SYNTHESIS: Optimal dosing of antibacterials is dependent on achieving pharmacokinetic targets associated with maximal killing of bacteria and improved outcomes. The initial dose is dependent on the volume of distribution. Maintenance doses are dependent on clearance. Both should be adjusted according to the pharmacokinetic target associated with optimal bacterial killing, when known. The volume of distribution of some antibacterials is altered by critical illness or acute renal failure or both. Clearance by CRRT is dependent on the dose and mode of CRRT and the sieving or saturation coefficient of the drug. Both sieving and saturation coefficient are related to the plasma protein binding and thus may be altered in renal failure. CONCLUSIONS: Appropriate dose calculation requires knowledge of the pharmacokinetic target and the usual minimum inhibitory concentration of the suspected organism in the patient's locality (or if unavailable, the break point for the organism), published pharmacokinetic data (volume of distribution, non-CRRT clearance) on critically ill patients receiving CRRT (which may differ substantially from noncritically ill patients or those without renal failure), the sieving or saturation coefficient of the relevant drug in critically ill patients, the dose and mode of CRRT being used, and the actual dose of CRRT that is delivered. This large number of variables results in considerable inter- and intrapatient heterogeneity in dose requirements. This article provides basic principles and relevant data to guide the clinician in prescribing individualized dosing regimes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ccm.0b013e3181aab3d0

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 57

  1. Rahman, 2002, Clin Med, 2, 108, 10.7861/clinmedicine.2-2-108 · doi:10.7861/clinmedicine.2-2-108
  2. Rangel-Frausto, 1995, JAMA, 273, 117, 10.1001/jama.1995.03520260039030 · DOI · Paper page
  3. Kubin, 2005, J Pharm Pract, 18, 109, 10.1177/0897190004273596 · doi:10.1177/0897190004273596
  4. Burgess, 1999, Chest, 115, 19S, 10.1378/chest.115.suppl_1.19S · doi:10.1378/chest.115.suppl_1.19s
  5. Tessier, 1999, Chemotherapy, 45, 284, 10.1159/000007198 · doi:10.1159/000007198
  6. Ronco, 2001, Nephrol Dial Transplant, 16, 67, 10.1093/ndt/16.suppl_5.67 · doi:10.1093/ndt/16.suppl_5.67
  7. Oda, 2002, Ther Apher, 6, 193, 10.1046/j.1526-0968.2002.00431.x · doi:10.1046/j.1526-0968.2002.00431.x
  8. Golper, 1998, Kidney Int Suppl, 66, S165
  9. Golper, 2001, Contrib Nephrol, &NA;, 349, 10.1159/000060103 · doi:10.1159/000060103
  10. Guenter, 2002, Pharmacotherapy, 22, 175, 10.1592/phco.22.3.175.33546 · doi:10.1592/phco.22.3.175.33546
  11. Malone, 2001, Antimicrob Agents Chemother, 45, 2949, 10.1128/AAC.45.10.2949-2954.2001 · doi:10.1128/aac.45.10.2949-2954.2001
  12. Hansen, 2001, Intensive Care Med, 27, 371, 10.1007/s001340000836 · doi:10.1007/s001340000836
  13. Traunmüller, 2001, J Antimicrob Chemother, 47, 229, 10.1093/jac/47.2.229 · doi:10.1093/jac/47.2.229
  14. Choi, 2004, Int J Antimicrob Agents, 24, 468
  15. Troyanov, 2003, Nephrol Dial Transplant, 18, 961, 10.1093/ndt/gfg055 · doi:10.1093/ndt/gfg055
  16. Lipman, 1998, Antimicrob Agents Chemother, 42, 2235, 10.1128/AAC.42.9.2235 · doi:10.1128/aac.42.9.2235
  17. Wallis, 2001, Intensive Care Med, 27, 665, 10.1007/s001340100857 · doi:10.1007/s001340100857
  18. Giles, 2000, Crit Care Med, 28, 632, 10.1097/00003246-200003000-00005 · doi:10.1097/00003246-200003000-00005
  19. Ververs, 2000, Crit Care Med, 28, 3412, 10.1097/00003246-200010000-00006 · doi:10.1097/00003246-200010000-00006
  20. Isla, 2007, Chemotherapy, 53, 194, 10.1159/000100864 · doi:10.1159/000100864
  21. Hassan, 1987, Antimicrob Agents Chemother, 31, 1855, 10.1128/AAC.31.11.1855 · doi:10.1128/aac.31.11.1855
  22. Jones, 1997, J Antimicrob Chemother, 40, 121, 10.1093/jac/40.1.121 · doi:10.1093/jac/40.1.121
  23. Tian, 2008, Antimicrob Agents Chemother, 52, 1009, 10.1128/AAC.00858-07 · doi:10.1128/aac.00858-07
  24. Meyers, 1983, Antimicrob Agents Chemother, 24, 812, 10.1128/AAC.24.5.812 · doi:10.1128/aac.24.5.812
  25. Gonzalez, 1985, Clin Pharmacol Ther, 37, 633, 10.1038/clpt.1985.102 · doi:10.1038/clpt.1985.102
  26. de Pont, 2007, Curr Opin Crit Care, 13, 668, 10.1097/MCC.0b013e3282f0febd · doi:10.1097/mcc.0b013e3282f0febd
  27. Tian, 2008, Artif Organs, 32, 81, 10.1111/j.1525-1594.2007.00460.x · doi:10.1111/j.1525-1594.2007.00460.x
  28. Leone, 2004, Antimicrob Agents Chemother, 48, 638, 10.1128/AAC.48.2.638-640.2004 · doi:10.1128/aac.48.2.638-640.2004
  29. Rubinstein, 2002, J Antimicrob Chemother, 49, 593, 10.1093/jac/49.4.593 · doi:10.1093/jac/49.4.593
  30. Capellier, 1998, Crit Care Med, 26, 88, 10.1097/00003246-199801000-00021 · doi:10.1097/00003246-199801000-00021
  31. Keller, 1995, Clin Nephrol, 43, S20
  32. Meyer, 2003, Kidney Blood Press Res, 26, 135, 10.1159/000070997 · doi:10.1159/000070997
  33. Davies, 1991, Nephrol Dial Transplant, 6, 971, 10.1093/ndt/6.12.971 · doi:10.1093/ndt/6.12.971
  34. Weiss, 1988, Clin Nephrol, 30, 282
  35. Traunmuller, 2002, J Antimicrob Chemother, 49, 129, 10.1093/jac/49.1.129 · doi:10.1093/jac/49.1.129
  36. Matzke, 2000, Antimicrob Agents Chemother, 44, 1639, 10.1128/AAC.44.6.1639-1644.2000 · doi:10.1128/aac.44.6.1639-1644.2000
  37. Kroh, 1996, J Clin Pharmacol, 36, 1114, 10.1002/j.1552-4604.1996.tb04164.x · doi:10.1002/j.1552-4604.1996.tb04164.x
  38. Isla, 2005, Clin Ther, 27, 599, 10.1016/j.clinthera.2005.05.004 · doi:10.1016/j.clinthera.2005.05.004
  39. Keller, 1989, Nephrol Dial Transplant, 4, 640
  40. Tegeder, 1997, Antimicrob Agents Chemother, 41, 2640, 10.1128/AAC.41.12.2640 · doi:10.1128/aac.41.12.2640
  41. Hashimoto, 1997, ASAIO J, 43, 84
  42. Tegeder, 1999, Clin Pharmacol Ther, 65, 50, 10.1016/S0009-9236(99)70121-9 · doi:10.1016/s0009-9236(99)70121-9
  43. Fuhrmann, 2004, J Antimicrob Chemother, 54, 780, 10.1093/jac/dkh421 · doi:10.1093/jac/dkh421
  44. Barrie, 1992, Intensive Care Med, 18, 437, 10.1007/BF01694350 · doi:10.1007/bf01694350
  45. DelDot, 2004, Br J Clin Pharmacol, 58, 259, 10.1111/j.1365-2125.2004.02143.x · doi:10.1111/j.1365-2125.2004.02143.x
  46. Boereboom, 1999, Intensive Care Med, 25, 1100, 10.1007/s001340051018 · doi:10.1007/s001340051018
  47. Yagasaki, 2003, Intensive Care Med, 29, 2094, 10.1007/s00134-003-1914-9 · doi:10.1007/s00134-003-1914-9
  48. Pea, 2001, Drug Monit, 23, 587, 10.1097/00007691-200110000-00013 · doi:10.1097/00007691-200110000-00013
  49. Wolter, 1994, Eur J Clin Pharmacol, 46, 179, 10.1007/BF00199886 · doi:10.1007/bf00199886
  50. Zarowitz, 1986, J Clin Pharmacol, 26, 686, 10.1002/j.1552-4604.1986.tb02973.x · doi:10.1002/j.1552-4604.1986.tb02973.x
  51. Ernest, 1992, Crit Care Med, 20, 586, 10.1097/00003246-199205000-00007 · doi:10.1097/00003246-199205000-00007
  52. Syka, 2005, J Clin Pharmacol, 45, 477, 10.1177/0091270004273949 · doi:10.1177/0091270004273949
  53. Robert, 1991, Crit Care Med, 19, 588, 10.1097/00003246-199104000-00029 · doi:10.1097/00003246-199104000-00029
  54. Moon, 2006, Korean J Nephrol, 25, 595
  55. Pea, 2004, Am J Kidney Dis, 44, 1097, 10.1053/j.ajkd.2004.08.032 · doi:10.1053/j.ajkd.2004.08.032
  56. Meyer, 2005, J Antimicrob Chemother, 56, 172, 10.1093/jac/dki133 · doi:10.1093/jac/dki133
  57. Churchwell, 2006, Blood Purif, 24, 548, 10.1159/000097078 · doi:10.1159/000097078

Cited by

See all 334

Metadata

Authors
Choi, G., Gomersall, C. D., Tian, Q., Joynt, G. M., Freebairn, R., & Lipman, J.
Venue
Critical Care Medicine
Published
2009-07
Volume
37
Issue
7
Pages
2268-2282
ISSN
0090-3493 (ISSN-L)
OpenAlex
W2017487363
Cited by
334
References
95
FWCI
11.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.